GGrantIndex
← Leaderboards

John D. Catravas

Medical College Of Georgia (Mcg)

Google Scholar ↗PubMed ↗ORCID ↗
$9,013,438
Attributed
$9,013,438
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY2005–22
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$9,013,438 · 9

By mechanism

R01$3,227,139 · 3
T32$2,844,648 · 1
U01$1,351,601 · 1
R21$852,500 · 2
P01$737,550 · 2

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Acute”

Research focus

AcuteFunctional DisorderHeat-Shock Proteins 90ExhibitsIncidenceMolecular ChaperonesPharmaceutical PreparationsInhibitor/AntagonistAnti-Inflammatory AgentsChronicLungLung InjuryAnimal ModelMouse ModelEffectivenessAntidotesHourDoseClinical InvestigationChemical WarfareClinical TrialsAftercareEventExposure To

Grant awards (31)

Antidotes against HCI-induced chronic lung injury$440,014
U01 · FY2022 · ES · contact PI
Antidotes against HCI-induced chronic lung injury$452,829
U01 · FY2021 · ES · contact PI
Antidotes against HCI-induced chronic lung injury$458,758
U01 · FY2020 · ES · contact PI
Antidotes against mustard-induced chronic lung injury$193,750
R21 · FY2019 · ES · contact PI
Antidotes against mustard-induced chronic lung injury$232,500
R21 · FY2018 · ES · contact PI
Antidotes against Hydrochloric Acid-Induced Chronic Lung Injury$193,750
R21 · FY2018 · ES · contact PI
Antidotes against Hydrochloric Acid-Induced Chronic Lung Injury$232,500
R21 · FY2017 · ES · contact PI
VASCULAR ANTI-INFLAMMATORY ACTIONS OF HSP90 INHIBITORS$191,829
R01 · FY2013 · HL · contact PI
VASCULAR ANTI-INFLAMMATORY ACTIONS OF HSP90 INHIBITORS$154,532
R01 · FY2013 · HL · contact PI
VASCULAR ANTI-INFLAMMATORY ACTIONS OF HSP90 INHIBITORS$363,825
R01 · FY2012 · HL · contact PI
Human Tissue & Animal Core Unit$387,400
P01 · FY2011 · HL · contact PI
VASCULAR ANTI-INFLAMMATORY ACTIONS OF HSP90 INHIBITORS$367,500
R01 · FY2011 · HL · contact PI
Therapeutic Mechanisms of RhoA Inhibition In Acute Lung Injury$350,150
P01 · FY2011 · HL · contact PI
VASCULAR ANTI-INFLAMMATORY ACTIONS OF HSP90 INHIBITORS$367,500
R01 · FY2010 · HL · contact PI
POST-DOCTORAL TRAINING PROGRAM IN INTEGRATIVE CARDIOVASCULAR BIOLOGY$226,686
T32 · FY2010 · HL · contact PI
POST-DOCTORAL TRAINING PROGRAM IN INTEGRATIVE CARDIOVASCULAR BIOLOGY$334,862
T32 · FY2009 · HL · contact PI
POST-DOCTORAL TRAINING PROGRAM IN INTEGRATIVE CARDIOVASCULAR BIOLOGY$332,167
T32 · FY2008 · HL · contact PI
POST-DOCTORAL TRAINING PROGRAM IN INTEGRATIVE CARDIOVASCULAR BIOLOGY$332,167
T32 · FY2007 · HL · contact PI
POST-DOCTORAL TRAINING PROGRAM IN INTEGRATIVE CARDIOVASCULAR BIOLOGY$317,877
T32 · FY2006 · HL · contact PI
REGULATION OF sGC IN sGC/Hsp90/NOS COMPLEXES$314,190
R01 · FY2006 · HL · contact PI
REGULATION OF sGC IN sGC/Hsp90/NOS COMPLEXES$321,750
R01 · FY2005 · HL
TRAINING IN INTEGRATIVE CARDIOVASCULAR BIOLOGY$296,007
T32 · FY2005 · HL
REGULATION OF sGC IN sGC/Hsp90/NOS COMPLEXES$85,000
R01 · FY2005 · HL
REGULATION OF sGC IN sGC/Hsp90/NOS COMPLEXES$321,750
R01 · FY2004 · HL
Training in Integrative Cardiovascular Biology$293,829
T32 · FY2004 · HL
REGULATION OF sGC IN sGC/Hsp90/NOS COMPLEXES$322,032
R01 · FY2003 · HL
TRAINING IN INTEGRATIVE CARDIOVASCULAR BIOLOGY$312,590
T32 · FY2003 · HL
TRAINING IN INTEGRATIVE CARDIOVASCULAR BIOLOGY$275,401
T32 · FY2002 · HL
TOXICOLOGY AND PHARMACOLOGY OF LUNG ENDOTHELIAL ENZYMES$210,941
R01 · FY2001 · HL
TRAINING IN INTEGRATIVE CARDIOVASCULAR BIOLOGY$123,062
T32 · FY2001 · HL
TOXICOLOGY AND PHARMACOLOGY OF LUNG ENDOTHELIAL ENZYMES$206,290
R01 · FY2000 · HL